Christopher Simms - Dec 20, 2022 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role: SVP, Chief Commercial Officer
Signature: /s/ Todd D.C. Anderman, as Attorney-in-Fact for Christopher Simms
Stock symbol: ISEE
Transactions as of: Dec 20, 2022
Transactions value $: $0
Form type: 4
Date filed: 12/22/2022, 05:54 PM
Previous filing: Aug 4, 2022
Next filing: Jan 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISEE	Stock Option (right to buy)	Award	$0	+75K		$0.00	75K	Dec 20, 2022	Common Stock	75K	$22.57	Direct	F1
transaction	ISEE	Restricted Stock Units	Award	$0	+37.5K		$0.00	37.5K	Dec 20, 2022	Common Stock	37.5K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares, in approximately equal monthly installments through the fourth anniversary of the grant date.
F2	Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
F3	Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award in annual installments (on January 2, 2024, January 2, 2025, January 2, 2026 and January 2, 2027).